Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.125 USD | +0.45% | -3.02% | +6.13% |
Evolution of the average Target Price on SELLAS Life Sciences Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering SELLAS Life Sciences Group, Inc.
Cantor Fitzgerald | |
Alliance Global Partners | |
Ladenburg Thalmann | |
Maxim |
EPS Revisions
- Stock Market
- Equities
- SLS Stock
- Consensus SELLAS Life Sciences Group, Inc.